Killing wisely: precision senolytics in the age of frailty
Genes & Development · 2025
DOI: 10.1101/gad.353134.125 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Genes & Development, 2025. Verfasst von Valentin J A Barthet und 1 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA. Hauptthemen laut MEDLINE: Cellular Senescence, Senotherapeutics, Frailty, Aging. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIA NIH HHS, Francois Wallace Monahan Postdoctoral Fellowship.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Cellular senescence plays a dual role in tissue biology by promoting tumor suppression and wound healing when transient but driving inflammation, fibrosis, and age-related disease when persistent. The growing recognition that senescent cell clearance can reverse these pathologies has catalyzed efforts to develop therapeutics that preferentially kill senescent cells (also known as “senolytics”). However, clinical translation from bench to bedside remains challenging due to senescent state heterogeneity, limited biomarkers, off-target toxicities, and the frailty of aged patients. Small molecule senolytics, although promising, often lack defined mechanisms of action and pose safety concerns that may constrain their use in older adults. Emerging precision approaches, including those that exploit surface markers and leverage engineered immune therapies, offer a rational and potentially more selective path forward. Here we highlight recent advances in senescence profiling and targeted clearance strategies, emphasizing the need for therapies designed with both biological complexity and the needs of aging populations in mind.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.
- Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA; lowes@mskcc.org.
- Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.
Förderung
- NCI NIH HHS
- NIA NIH HHS
- Francois Wallace Monahan Postdoctoral Fellowship
- Cancer Research Institute Irvington Postdoctoral Fellowship
Zitieren
APA
Barthet, V. J. A., & Lowe, S. W. (2025). Killing wisely: precision senolytics in the age of frailty. Genes & Development. https://doi.org/10.1101/gad.353134.125
Vancouver
Barthet VJA, Lowe SW. Killing wisely: precision senolytics in the age of frailty. Genes & Development. 2025. doi:10.1101/gad.353134.125
BibTeX
@article{Barthet2025,
author = {Barthet, Valentin J A and Lowe, Scott W},
title = {Killing wisely: precision senolytics in the age of frailty},
journal = {Genes & Development},
year = {2025},
doi = {10.1101/gad.353134.125}
}
EUVIMED